Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma

NCT04656431 is registered in ClinicalTrials.gov with James Rubenstein as lead sponsor.

NCT NCT04656431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04656431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma
Lead sponsor
James Rubenstein
Phase
Phase 1
Overall status
Recruiting
Start date
June 29, 2021
Completion date
March 31, 2027
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary cns lymphoma